JP2015505295A5 - - Google Patents

Download PDF

Info

Publication number
JP2015505295A5
JP2015505295A5 JP2014512088A JP2014512088A JP2015505295A5 JP 2015505295 A5 JP2015505295 A5 JP 2015505295A5 JP 2014512088 A JP2014512088 A JP 2014512088A JP 2014512088 A JP2014512088 A JP 2014512088A JP 2015505295 A5 JP2015505295 A5 JP 2015505295A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
article
container
dosage form
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014512088A
Other languages
English (en)
Japanese (ja)
Other versions
JP6072778B2 (ja
JP2015505295A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/039219 external-priority patent/WO2012162439A2/en
Publication of JP2015505295A publication Critical patent/JP2015505295A/ja
Publication of JP2015505295A5 publication Critical patent/JP2015505295A5/ja
Application granted granted Critical
Publication of JP6072778B2 publication Critical patent/JP6072778B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014512088A 2011-05-23 2012-05-23 フシジン酸を含む組成物およびそのためのパッケージ Active JP6072778B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161489017P 2011-05-23 2011-05-23
US61/489,017 2011-05-23
PCT/US2012/039219 WO2012162439A2 (en) 2011-05-23 2012-05-23 Compositions comprising fusidic acid and packages therefor

Publications (3)

Publication Number Publication Date
JP2015505295A JP2015505295A (ja) 2015-02-19
JP2015505295A5 true JP2015505295A5 (https=) 2015-07-16
JP6072778B2 JP6072778B2 (ja) 2017-02-01

Family

ID=47218064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014512088A Active JP6072778B2 (ja) 2011-05-23 2012-05-23 フシジン酸を含む組成物およびそのためのパッケージ

Country Status (3)

Country Link
US (4) US20140088062A1 (https=)
JP (1) JP6072778B2 (https=)
WO (1) WO2012162439A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ，インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300073A1 (en) * 1987-07-22 1989-01-25 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Use of fusidic acid in the treatment of aids-related complex and full-blown aids
US6103884A (en) * 1996-03-27 2000-08-15 The University Of Michigan Glycosylated analogs of fusidic acid
JPH11189547A (ja) * 1997-12-26 1999-07-13 Taisho Pharmaceut Co Ltd 安定化されたニコランジル製剤及びその製造方法
JP2005103148A (ja) * 2003-10-01 2005-04-21 Nisshin Kyorin Pharmaceutical Co Ltd ５−アミノサリチル酸の保存方法及び保存システム
US20070155780A1 (en) * 2004-04-15 2007-07-05 Hitoshi Nakata Stabilized composition containing 4-amino-5-chloro-n-[(1r, 3r, 5s)-8-methyl-8-azabicyclo[3.2.1]oct-3-y1]-2-[1-methylbut-2-ynyloxy]benzamide
ZA200701036B (en) * 2004-07-16 2008-05-28 Cipla Ltd Anti-histaminic composition
US20060076536A1 (en) * 2004-09-29 2006-04-13 Barshied Scott R Oxygen scavenging pharmaceutical package and methods for making same
EP1977734A1 (en) * 2007-04-03 2008-10-08 Royal College of Surgeons in Ireland A method of producing fast dissolving tablets
CN100566704C (zh) * 2007-10-12 2009-12-09 西藏康欣药业有限公司 夫西地酸钠冻干粉针剂
WO2009128932A1 (en) * 2008-04-15 2009-10-22 Sarcode Corporation Delivery of lfa-1 antagonists to the gastrointestinal system
CN102325524B (zh) * 2009-02-18 2013-10-09 苏鲁·苏布拉马尼·瓦南加穆迪 一种制备夫西地酸乳膏的方法
US20120035144A1 (en) * 2009-04-20 2012-02-09 Apex Laboratories Private Limited Medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a corticosteroid, and an antifungal agent, and a process to make it.
US8450300B2 (en) * 2009-07-13 2013-05-28 Cempra Pharmaceuticals Inc. Fusidic acid dosing regimens for treatment of bacterial infections

Similar Documents

Publication Publication Date Title
JP2015505295A5 (https=)
JP2010132695A5 (https=)
BR112013032122A2 (pt) liberação modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)fenil] benzamida solubilizada usando ácidos orgânicos
JP2015078230A5 (https=)
JP2012255026A5 (https=)
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
JP2013520405A5 (https=)
JP2010222367A5 (https=)
JP2016510019A5 (https=)
MX345404B (es) Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol- 2-il]-1h-quinolin-2-ona.
JP2012236834A5 (https=)
WO2012035480A3 (en) Pharmaceutical compositions of curcumin
JP2010520246A5 (https=)
JP2014530801A5 (https=)
JP2013516493A5 (https=)
JP2013518051A5 (https=)
ECSP13012399A (es) Un nuevo conjugado de granulocito colonia-estimulante factor (g-csf) con polietileno
HK1203050A1 (en) Novel dosage and formulation
JP2018039810A5 (https=)
PH12014500191A1 (en) Use of organic compound for the treatment of noonan syndrome
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
WO2011093818A3 (en) Pharmaceutical compositions comprising salmeterol and fluticasone
JP2016537364A5 (https=)
JP2015521647A5 (https=)
JP2016540799A5 (https=)